Announcement on Implementation of Semi-annual Dividend Distribution for 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
Filed with SSE · · 4 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-implementation-of-semi-annual-dividend-distribution-for-2025-216
Release
Hunan Fangsheng Pharmaceutical Co., Ltd. on 6ix
Earlier from Hunan Fangsheng Pharmaceutical
- Announcement on Obtaining Notice of Approval for Drug Clinical Trials by A Holding Subsidiary for Traditional Chinese Medicine Innovative Drug Research Project
- Announcement on Outline of the 2025 Semi-annual Performance Briefing
- 2025 Semi-annual Report
- Announcement on Progress in the Sale of Partial Equity in Investment Projects by the M&A Fund Participated and Established by the Company
- Announcement on Convening the 2025 Semi-annual Performance Briefing
Later from Hunan Fangsheng Pharmaceutical
- Announcement on Obtaining Summary Report of Phase II Clinical Trial for Zhilong Tongluo Tablets
- Announcement on Drug Marketing Authorization Transfer
- Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Change of ""Drug Manufacturing License"
Follow Hunan Fangsheng Pharmaceutical into a list and get an email when it puts out news.
Follow Hunan Fangsheng Pharmaceutical